174 Myocardial perfusion by intravenous echo contrast and by nuclear imaging

1999 ◽  
Vol 1 ◽  
pp. S31-S31
Author(s):  
M MORALES ◽  
D ROVAI ◽  
A GIMELLI ◽  
C MARINI ◽  
U STARTARI ◽  
...  
2017 ◽  
Vol 02 (02) ◽  
pp. 032-037
Author(s):  
Gopi Kenchi ◽  
N. Kavitha ◽  
Madhur Srivastava

AbstractBackground: Appropriate usage Criteria (AUC) for nuclear imaging exams were created by American College of Cardiology (ACC) e American Society of Nuclear Cardiology (ASNC) to allow the rational use of tests. Little is known whether these criteria have been followed in clinical practice. Objective: To evaluate whether the medical applications of myocardial perfusion scintigraphy (MPS) in a tertiary cardiology hospital were suitable to the criteria of indications proposed by the American medical societies in 2009.Methods: We included records of patients who undergone MPS, from April 2016 up to August 2016. Demographic characteristics, patient's origin, coronary risk factors, clinical presentation, ECG, 2d echocardiogram, TMT and AUC of medical applications were studied. The criteria were evaluated by two independent cardiologists and, in doubtful cases, defined by a medical expert in MPS.Results: Total no of cases included in the study were 334 patients. Mean age was 62 ± 10 years. Of the 334 records reviewed, 201 (60.17%) studies were performed in men and 133 (39.8%) were performed in women. With ACC 2009, 168 (50.29%) were considered appropriate indications and 166 (49.70%) were considered inappropriate and uncertain indications. The AUC Sensitivity is 78.8, Specificity of 58.7%, Positive Predictive Value of 37.5% and Negative Predictive Value of 89.8%.Conclusions: In 63(18.8%) of patients MPS investigation is used appropriately to detect the CAD according to ACC & ASNC guidelines of 2009.


Author(s):  
Stefan Möhlenkamp

Myocardial perfusion imaging using single photon emission computed tomography (SPECT) by means of scintigraphy is an established non-invasive method for detecting coronary artery disease (CAD) and improving risk stratification in symptomatic individuals. Data on its diagnostic and prognostic role and value in athletes are sparse. Possibly in part due to exercise-induced improved myocardial microvascular morphology and function, a mismatch between advanced coronary atherosclerosis burden and comparatively small myocardial perfusion defects has been reported in athletes. Because of radiation exposure and the costs of the test a careful risk–benefit assessment is necessary, particularly in asymptomatic athletes with risk factors and young athletes.


1999 ◽  
Vol 1 ◽  
pp. S4-S4
Author(s):  
M MORALES ◽  
D ROVAI ◽  
A GIMELLI ◽  
C MARINI ◽  
U STARTARI ◽  
...  

2016 ◽  
Vol 21 (1) ◽  
pp. 2
Author(s):  
Mark A Friedman

Ultrasound contrast agents are widely used in clinical practice for left ventricle opacification in sub-optimal echocardiograms. Recently, significant research has focused on the use of contrast echocardiography as a non invasive means to evaluate myocardial perfusion. Advances in contrast agents as well as ultrasound technology have enabled investigations into myocardial contrast echocardiography as a possible alternative to nuclear imaging studies. This review will focus on the development and current uses of contrast echocardiography, as well as future indications, including myocardial perfusion and risk stratification following myocardial infarction. 


Sign in / Sign up

Export Citation Format

Share Document